Table 3. Multivariable GLM results for the total healthcare cost for one year among ECMO survivors.
Variables | Multivariable model, Exp (B) (95% CI) |
P |
---|---|---|
Age, years | 1.01 (1.00, 1.01) | <0.001 |
Sex, male | 1.07 (1.04, 1.10) | <0.001 |
Residence at ECMO support | ||
Urban area | 1 | |
Rural area | 1.02 (1.00, 1.04) | 0.189 |
Year of ECMO support | ||
2005–2008 | 1 | |
2009–2012 | 1.34 (1.28, 1.40) | <0.001 |
2013–2015 | 1.65 (1.57, 1.72) | <0.001 |
2016–2018 | 2.07 (1.98, 2.16) | <0.001 |
Annual income level at ECMO support | ||
Q1 (lowest) | 1 | |
Q2 | 1.01 (0.97, 1.04) | 0.673 |
Q3 | 1.02 (0.99, 1.06) | 0.174 |
Q4 (highest) | 1.00 (0.97, 1.03) | 0.957 |
Annual case volume of ECMO support | ||
Q1 <15 | 1 | |
Q2: 15–28 | 1.06 (1.02, 1.10) | 0.002 |
Q3: 29–63 | 1.18 (1.14, 1.22) | <0.001 |
Q4 >63 | 1.59 (1.53, 1.64) | <0.001 |
Charlson comorbidity index | 1.01 (1.01, 1.02) | <0.001 |
Total number of hospital-visit days for 1-year | 1.01 (1.00, 1.01) | <0.001 |
Duration of ECMO support | 1.02 (1.01, 1.02) | <0.001 |
Length of hospital stay at ECMO support | 1.01 (1.01, 1.02) | <0.001 |
Follow up after discharge | ||
Follow up in the same hospital | 1 | |
Transfer to other long-term facility care center | 0.92 (0.86, 0.97) | 0.004 |
Discharge to home, and outpatient clinic follow up | 1.31 (1.27, 1.35) | <0.001 |
Main diagnosis at ECMO treatment | ||
Cardiac indication group | 1 | |
Respiratory indication group | 0.89 (0.86, 0.93) | <0.001 |
Other | 1.31 (1.27, 1.35) | <0.001 |
GLM, generalized linear regression model; ECMO, extracorporeal membrane oxygenation.